Skip to main content

Advertisement

Log in

Management of Painful Pelvic Bone Metastasis of Renal Cell Carcinoma Using Embolization, Radio-frequency Ablation, and Cementoplasty: A Prospective Evaluation of Efficacy and Safety

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To measure the impact on pain relief and patient quality of life using embolization radio-frequency ablation and cementoplasty (ERC) for local combination therapeutic management of painful pelvic bone metastasis of renal cell carcinoma (RCC).

Materials and Methods

This prospective monocentric registry was approved by our Local Institutional Review Board. Between January 2008 and January 2013, all consecutive patients who fully met the inclusion criteria were enrolled in the ERC-procedure prospective registry. They were assigned to follow-up at discharge and again at 1 and 6 months. Efficacy was evaluated using a pain visual analog scale (VAS), and narcotic consumption and quality of life were assessed using the Brief Pain Inventory questionnaire.

Results

Fifty-two patients were enrolled, among whom 58 lesions were treated. Technical success was obtained in all procedures. The median VAS score decreased from 7 ± 1.4 (ranges 5–10) at baseline to 3 ± 1.5 (ranges 0–6) at discharge, 2 ± 1.5 (ranges 0–5) at 1 month (p < 0.0001), and 2 ± 1.6 (ranges 0–5) at 6 months. In 28 patients (54 %), narcotic consumption was halved at discharge and halved in 40 (77 %) patients at 1 and 6 months compared with baseline. Five patients had complete pain relief at 1 month. A major improvement in quality of life, especially regarding mood and motion, was observed in all patients.

Conclusion

This specific approach to painful bone metastasis is efficient and safe and yields sustained results. The ERC procedure could be suggested for patients with RCC bone metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

RCC:

Renal cell cancer

ECOGps:

Eastern Cooperative Oncology Group Performance Status

ASA:

American Society of Anesthesiologists

ERC:

Embolization radio-frequency ablation and cementoplasty

RFA:

Radio-Frequency Ablation

BPI:

Brief pain inventory

VAS:

Visual analog scale

PMMA:

Polymethyl methacrylate

PCA:

Patient control analgesia

MED:

Morphine-equivalent daily dose

References

  1. Badalian G, Derecskei K, Szendroi A, Szendroi M, Timar J (2007) EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer. Anticancer Res 27(2):889–894

    CAS  PubMed  Google Scholar 

  2. Beuselinck B, Oudard S, Rixe O et al (2011) Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann Oncol 22(4):794–800

    Article  CAS  PubMed  Google Scholar 

  3. Boureau F, Luu M, Doubrere JF, Gay C (1984) Construction of a questionnaire for the self-evaluation of pain using a list of qualifiers. Comparison with Melzack’s McGill Pain Questionnaire. Therapie 39(2):119–129

    CAS  PubMed  Google Scholar 

  4. Callstrom MR, Atwell TD, Charboneau JW et al (2006) Painful metastases involving bone: percutaneous image-guided cryoablation—Prospective trial interim analysis. Radiology 241(2):572–580

    Article  PubMed  Google Scholar 

  5. Callstrom MR, Dupuy DE, Solomon SB et al (2013) Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 119(5):1033–1041

    Article  PubMed  Google Scholar 

  6. Callstrom MR, York JD, Gaba RC et al (2009) Research reporting standards for image-guided ablation of bone and soft tissue tumors. J Vasc Interv Radiol 20(12):1527–1540

    Article  PubMed  Google Scholar 

  7. Carrafiello G, Dionigi G, Boni L et al (2011) Current role of interventions in metastatic kidney tumors: single center experience. Updates Surg 63(4):259–269

    Article  PubMed  Google Scholar 

  8. Carrafiello G, Lagana D, Pellegrino C et al (2009) Percutaneous imaging-guided ablation therapies in the treatment of symptomatic bone metastases: preliminary experience. Radiol Med 114(4):608–625

    Article  CAS  PubMed  Google Scholar 

  9. Chatziioannou AN, Johnson ME, Pneumaticos SG, Lawrence DD, Carrasco CH (2000) Preoperative embolization of bone metastases from renal cell carcinoma. Eur Radiol 10(4):593–596

    Article  CAS  PubMed  Google Scholar 

  10. Chiras J, Adem C, Vallee JN, Spelle L, Cormier E, Rose M (2004) Selective intra-arterial chemoembolization of pelvic and spine bone metastases. Eur Radiol 14(10):1774–1780

    Article  PubMed  Google Scholar 

  11. Courtheoux P, Alachkar F, Casasco A et al (1985) Chemoembolization of lumbar spine metastases A preliminary study. J Neuroradiol 12(2):151–162

    CAS  PubMed  Google Scholar 

  12. Emmanouilides C, Chourmouzi D, Dedes I, Pantoleon D, Mantziari P, Drevelengas A (2009) Successful management of bulky osseous metastasis of renal cell carcinoma with selective arterial embolization and radiofrequency ablation: a case report. Cases J 2:6484

    Article  PubMed Central  PubMed  Google Scholar 

  13. Forauer AR, Kent E, Cwikiel W, Esper P, Redman B (2007) Selective palliative transcatheter embolization of bony metastases from renal cell carcinoma. Acta Oncol 46(7):1012–1018

    Article  PubMed  Google Scholar 

  14. Guzman R, Dubach-Schwizer S, Heini P et al (2005) Preoperative transarterial embolization of vertebral metastases. Eur Spine J 14(3):263–268

    Article  PubMed Central  PubMed  Google Scholar 

  15. Haynes SR, Lawler PG (1995) An assessment of the consistency of ASA physical status classification allocation. Anaesthesia 50(3):195–199

    Article  CAS  PubMed  Google Scholar 

  16. Heran MK, Legiehn GM, Munk PL (2006) Current concepts and techniques in percutaneous vertebroplasty. Orthop Clin North Am 37(3):409–434 vii

    Article  PubMed  Google Scholar 

  17. Ishiyama H, Shibata A, Niino K, Hosoya T (2004) Relationship between morphine and radiotherapy for management of symptomatic bone metastases from lung cancer. Support Care Cancer 12(10):743–745

    Article  PubMed  Google Scholar 

  18. Kato T, Nemoto R, Mori H, Takahashi M, Harada M (1981) Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs. Cancer 48(3):674–680

    Article  CAS  PubMed  Google Scholar 

  19. Kickuth R, Waldherr C, Hoppe H et al (2008) Interventional management of hypervascular osseous metastasis: role of embolotherapy before orthopedic tumor resection and bone stabilization. AJR Am J Roentgenol 191(6):W240–W247

    Article  PubMed  Google Scholar 

  20. Lane MD, Le HB, Lee S et al (2011) Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patients. Skeletal Radiol 40(1):25–32

    Article  PubMed  Google Scholar 

  21. Mikami S, Katsube K, Oya M et al (2009) Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. J Pathol 218(4):530–539

    Article  CAS  PubMed  Google Scholar 

  22. Motzer RJ, Hutson TE, Tomczak P et al (2009) Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 27(22):3584–3590

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Nakatsuka A, Yamakado K, Maeda M et al (2004) Radiofrequency ablation combined with bone cement injection for the treatment of bone malignancies. J Vasc Interv Radiol 15(7):707–712

    Article  PubMed  Google Scholar 

  24. Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655

    Article  CAS  PubMed  Google Scholar 

  25. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E (2001) Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manag 22(2):672–687

    Article  CAS  Google Scholar 

  26. Pusceddu C, Sotgia B, Fele RM, Melis L (2013) Treatment of bone metastases with microwave thermal ablation. J Vasc Interv Radiol 24(2):229–233

    Article  PubMed  Google Scholar 

  27. Staahl C, Christrup LL, Andersen SD, Arendt-Nielsen L, Drewes AM (2006) A comparative study of oxycodone and morphine in a multimodal, tissue-differentiated experimental pain model. Pain 123(1–2):28–36

    Article  CAS  PubMed  Google Scholar 

  28. Staehler M, Haseke N, Stadler T et al (2010) Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multikinase inhibition with sunitinib in progressive metastatic renal cell cancer. Urol Oncol 30(3):290–293

    Article  PubMed  Google Scholar 

  29. Sun S, Lang EV (1998) Bone metastases from renal cell carcinoma: preoperative embolization. J Vasc Interv Radiol 9(2):263–269

    Article  CAS  PubMed  Google Scholar 

  30. Thacker PG, Callstrom MR, Curry TB et al (2011) Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients’ immediate response to radiofrequency ablation and cryoablation. AJR Am J Roentgenol 197(2):510–515

    Article  PubMed  Google Scholar 

  31. Urch C (2004) The pathophysiology of cancer-induced bone pain: current understanding. Palliat Med 18(4):267–274

    Article  PubMed  Google Scholar 

  32. Woodward E, Jagdev S, McParland L et al (2011) Skeletal complications and survival in renal cancer patients with bone metastases. Bone 48(1):160–166

    Article  PubMed  Google Scholar 

  33. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 121(3):417–424

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Zekri J, Ahmed N, Coleman RE, Hancock BW (2001) The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 19(2):379–382

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors acknowledge MingDe Lin PhD, for helpful comments and language editing.

Conflict of interest

All the authors have no conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olivier Pellerin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pellerin, O., Medioni, J., Vulser, C. et al. Management of Painful Pelvic Bone Metastasis of Renal Cell Carcinoma Using Embolization, Radio-frequency Ablation, and Cementoplasty: A Prospective Evaluation of Efficacy and Safety. Cardiovasc Intervent Radiol 37, 730–736 (2014). https://doi.org/10.1007/s00270-013-0740-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-013-0740-x

Keywords

Navigation